TickerFacts.

Anika Therapeutics, Inc. (ANIK): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$57.48M
As of 2025-12-31
$38.41M
As of 2026-06-30
$157.46M2009-12-31: $24.43M2010-12-31: $28.20M2011-12-31: $35.78M2012-12-31: $44.07M2013-12-31: $63.33M2014-12-31: $100.16M2015-12-31: $110.71M2016-12-31: $104.26M2017-12-31: $133.26M2018-12-31: $89.04M2019-12-31: $157.46M2020-12-31: $95.82M2021-12-31: $94.39M2022-12-31: $86.33M2023-12-31: $68.74M2024-12-31: $55.63M2025-12-31: $57.48M$57.48M
2009-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$57.48M+3.3%2026-03-03, Balance as of period end
2024-12-31$55.63M-19.1%2026-03-03, Balance as of period end
2023-12-31$68.74Mn/c2025-03-17, Balance as of period end
2022-12-31$86.33M-8.5%2024-03-15, Balance as of period end
2021-12-31$94.39M-1.5%2023-03-16, Balance as of period end
2020-12-31$95.82M-39.1%2022-03-11, Balance as of period end
2019-12-31$157.46M+76.8%2021-04-26, Balance as of period end
2018-12-31$89.04M-33.2%2020-03-06, Balance as of period end
2017-12-31$133.26M+27.8%2020-03-06, Balance as of period end
2016-12-31$104.26M-5.8%2019-02-27, Balance as of period end
2015-12-31$110.71M+10.5%2018-02-27, Balance as of period end
2014-12-31$100.16M+58.1%2017-02-24, Balance as of period end
2013-12-31$63.33M+43.7%2016-03-10, Balance as of period end
2012-12-31$44.07M+23.2%2015-03-13, Balance as of period end
2011-12-31$35.78M+26.9%2014-03-13, Balance as of period end
2010-12-31$28.20M+15.5%2013-03-14, Balance as of period end
2009-12-31$24.43Mn/a2012-03-13, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Anika Therapeutics, Inc. (ANIK)2025-12-31$57.48M+3.3%
Orasure Technologies Inc (OSUR)2025-12-31$199.28M-25.6%
Beta Bionics, Inc. (BBNX)2025-12-31$31.58M+3.8%
NeuroPace Inc (NPCE)2025-12-31$21.69M+61.5%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$99.71M-58.0%
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$17.05M+175.1%
Pulmonx Corp (LUNG)2025-12-31$69.75M-1.6%
InfuSystem Holdings, Inc (INFU)2025-12-31$3.19M+504.6%
Neuronetics, Inc. (STIM)2025-12-31$28.13M+52.4%

Compare ANIK, OSUR, BBNX, NPCE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗